top of page

Rapid Implementation of ARV Multi-Month Dispensing during COVID-19


In an effort to decongest facilities and limit exposure of people living with HIV (PLHIV) to COVID-19, national programs should prioritize scaling access to multi-month dispensing (MMD) of anti retrovirals (ARVs) to stable patients. MMD will ensure PLHIV minimize time spent at facilities and ensure healthcare workers (HCWs) focus efforts towards more complicated HIV (or eventually COVID-19) cases. This memo focuses on scaling MMD access to stable PLHIV.




19 views

Comments


  • LinkedIn
  • Facebook
  • Twitter
  • Instagram
  • YouTube

383 Dorchester Avenue, Suite 400

Boston, MA 02127

The goal of the HIV New Product Introduction Toolkit is to stimulate conversations between government, partners, and communities on new product introduction. Please feel free to share any thoughts, questions, or additional resources for consideration by contacting us via email at HIVToolkit@clintonhealthaccess.org.

 

© 2022  Clinton Health Access Initiative - Global HIV Access Program

bottom of page